Total Visits

Views
Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial28

Select a period of time:

Views

Views
October 20240
November 20240
December 20240
January 20251
February 20251
March 202517
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United Kingdom2
 

Top cities views

Views